Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Maclean M. Cook"'
Autor:
Christopher W. Lewis, Jamiluddin Qazi, Daniel S. Hippe, Kristina Lachance, Hannah Thomas, Maclean M. Cook, Ilsa Juhlin, Neha Singh, Zoe Thuesmunn, Seesha R. Takagishi, Aubriana McEvoy, Coley Doolittle‐Amieva, Shailender Bhatia, Kelly G. Paulson, Ryan B. O'Malley, Carolyn L. Wang, Paul Nghiem
Publikováno v:
Cancer Medicine, Vol 9, Iss 4, Pp 1374-1382 (2020)
Abstract Approximately one‐third of Merkel cell carcinoma (MCC) patients eventually develop distant metastatic disease. Little is known about whether the location of the primary lesion is predictive of initial distant metastatic site, or if surviva
Externí odkaz:
https://doaj.org/article/cd52a0916ab148a6ba481cdfe0252487
Autor:
Peter H. Goff, MD, PhD, Stephanie K. Schaub, MD, Maclean M. Cook, BS, Paul N. Nghiem, MD, PhD, Upendra Parvathaneni, MBBS, FRANZCR
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100685- (2021)
Externí odkaz:
https://doaj.org/article/d6790b1364de40b383a8c73e4ffc5333
Autor:
David M. Koelle, Paul Nghiem, Shailender Bhatia, Aude G. Chapuis, Kelly G. Paulson, Alexander L. Greninger, Hong Xie, Maclean M. Cook, Aric Colunga, Olga K. Afanasiev, Jayasri G. Iyer, Dafina Ibrani, Rima M. Kulikauskas, Candice D. Church, Mariliis Ott, Lichen Jing
Merkel cell carcinoma (MCC) is often caused by persistent expression of Merkel cell polyomavirus (MCPyV) T-antigen (T-Ag). These non-self proteins comprise about 400 amino acids (AA). Clinical responses to immune checkpoint inhibitors, seen in about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b9a294b7b6bf30cd0808d965f016936
https://doi.org/10.1158/2326-6066.c.6550341
https://doi.org/10.1158/2326-6066.c.6550341
Autor:
David M. Koelle, Paul Nghiem, Shailender Bhatia, Aude G. Chapuis, Kelly G. Paulson, Alexander L. Greninger, Hong Xie, Maclean M. Cook, Aric Colunga, Olga K. Afanasiev, Jayasri G. Iyer, Dafina Ibrani, Rima M. Kulikauskas, Candice D. Church, Mariliis Ott, Lichen Jing
Sup Tables 1-6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::837b363fa3c7ff4968d02a275139c5b9
https://doi.org/10.1158/2326-6066.22543638
https://doi.org/10.1158/2326-6066.22543638
Autor:
David M. Koelle, Paul Nghiem, Shailender Bhatia, Aude G. Chapuis, Kelly G. Paulson, Alexander L. Greninger, Hong Xie, Maclean M. Cook, Aric Colunga, Olga K. Afanasiev, Jayasri G. Iyer, Dafina Ibrani, Rima M. Kulikauskas, Candice D. Church, Mariliis Ott, Lichen Jing
Sup Figures 1-13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4114aa56b2c3c1064d3e8347f1a85b67
https://doi.org/10.1158/2326-6066.22543641.v1
https://doi.org/10.1158/2326-6066.22543641.v1
Autor:
Aubriana M. McEvoy, Kristina Lachance, Daniel S. Hippe, Kelsey Cahill, Yasman Moshiri, Christopher W. Lewis, Neha Singh, Song Y. Park, Zoe Thuesmunn, Maclean M. Cook, Nora A. Alexander, Lauren Zawacki, Hannah Thomas, Kelly G. Paulson, Paul Nghiem
Publikováno v:
JAMA Dermatol
IMPORTANCE: Merkel cell carcinoma (MCC) often behaves aggressively; however, disease-recurrence data are not captured in national databases, and it is unclear what proportion of patients with MCC experience a recurrence (estimates vary from 27%-77%).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26f64ab57f68398176f0d976fa7de80f
https://pubmed.ncbi.nlm.nih.gov/35195657
https://pubmed.ncbi.nlm.nih.gov/35195657
Autor:
Stephanie K. Schaub, Alex Fu, Peter H. Goff, Smith Apisarnthanarax, Shailender Bhatia, Maclean M. Cook, Song Youn Park, Upendra Parvathaneni, Jay J. Liao, Paul Nghiem, Daniel S. Hippe, Yolanda D. Tseng
Publikováno v:
Advances in Radiation Oncology
Purpose Conventionally fractionated, post-operative radiotherapy (cPORT; 50 Gy in 25 fractions) is considered for patients with Merkel cell carcinoma (MCC) to improve locoregional control. However, cPORT is associated with acute toxicity, especially
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9748af152626d4c7cbb227f09dd97703
https://doi.org/10.1016/j.adro.2020.07.003
https://doi.org/10.1016/j.adro.2020.07.003
Autor:
Aude G. Chapuis, Rima M. Kulikauskas, Aric Colunga, Hong Xie, Kelly G. Paulson, Paul Nghiem, Maclean M. Cook, Alexander L. Greninger, Olga K. Afanasiev, Jayasri G. Iyer, David M. Koelle, Lichen Jing, Mariliis Ott, Candice D. Church, Dafina Ibrani, Shailender Bhatia
Publikováno v:
Cancer Immunol Res
Merkel cell carcinoma (MCC) is often caused by persistent expression of Merkel cell polyomavirus (MCPyV) T-antigen (T-Ag). These non-self proteins comprise about 400 amino acids (AA). Clinical responses to immune checkpoint inhibitors, seen in about
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6357e34f8f52391095463a2338f76c6
https://doi.org/10.1158/2326-6066.cir-19-0647
https://doi.org/10.1158/2326-6066.cir-19-0647
Autor:
K. Lachance, Kelsey Baker, Maclean M. Cook, Mary W. Redman, Paul Nghiem, Upendra Parvathaneni, Yolanda D. Tseng, Shailender Bhatia, Macklin H. Nguyen
Publikováno v:
Am J Clin Oncol
Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer with higher incidence among whites, elderly, and immunosuppressed patients. Although immunosuppressed MCC patients are at higher risk of recurrence and MCC-related death, it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b3b8c0b6efd3c9edfb8b91cf2e5e88
https://doi.org/10.1097/coc.0000000000000482
https://doi.org/10.1097/coc.0000000000000482
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100685-(2021)
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100685-(2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929076f970479492c7e0770c76904d4a
https://pubmed.ncbi.nlm.nih.gov/34195497
https://pubmed.ncbi.nlm.nih.gov/34195497